Spero Therapeutics, Inc.SPRONASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 9 | 3↓67.1% | 49↑1482.4% | 104↑113.6% | 48↓53.8% |
| Gross Profit | -58 | 3↑105.3% | 49↑1482.4% | 52↑7.7% | -49↓193.2% |
| Operating Income | -79 | -88↓11.2% | -42↑52.0% | 21↑150.9% | -73↓441.5% |
| Net Income | -78 | -90↓14.7% | -46↑48.3% | 23↑149.1% | -69↓400.6% |
| EBITDA | -78 | -87↓11.3% | -43↑50.7% | 27↑163.2% | -72↓366.9% |
| EPS Diluted | -3.52 | -2.91↑17.3% | -1.23↑57.7% | 0.43↑135.0% | -1.27↓395.3% |